<strong>Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder</strong>

Abstract

Abstract:Major depression disorder is a seriously psychological disease，which was characterized by oxidative stress and inflammation in pathogenesis. Oxidative stress and inflammatory response can be induced by excessive activation of the sympathetic nerve and hypothalamic pituitary adrenal axis，which would increase the level of glucocorticoid significantly in depression individuals. Nrf2/ARE signaling pathway is the main antioxidant signaling pathway，Nrf2 as a transcription factor，can be combined with ARE in the nuclear and induce antioxidant enzymes expression. Previous studies showed that Nrf2 -/- mice with typical symptoms of depression，while treated with anti-infl ammatory drugs alleviate it signifi cantly，suggesting that the immune infl ammatory was involved in depression caused by Nrf2 deletion. This article will review the role of Nrf2 mediated oxidative stress and immune inflammation in depression，and provided the theoretical basis for Nrf2/ARE signaling pathway as a novel target for antidepressant development.

Key words:depression disorder,Nrf2,oxidative stress,inflammation,anti-oxidant

WANG Sha-sha，ZHANG Zhao，ZHANG Mei-jin，HU Jin-feng，CHEN Nai-hong.Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder[J]. Acta Neuropharmacologica, 2016, 6(3): 32-37.

References

[1] Eric J Nestler, Michel Barrot, Ralph J DiLeone, et al. Neurobiology of depression[J].Neuron, 2002, 34(1):13-25.

[2] Gaurav Patki, Naimesh Solanki, Fatin Atrooz, et al. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress[J].Brain Research, 2013, 1539: 73-86.

[3] Jiang Wei-dan, Tang Ren-jun, Liu Yang, et al. Manganese deficiency or excess caused the depression of intestinal immunity, induction of inflammation and dysfunction of the intestinal physical barrier, as regulated by NF-kappaB, TOR and Nrf2 signalling, in grass carp (Ctenopharyngodon idella)[J].Fish & Shellfish Immunology, 2015, 46(2): 406-416.

[4] Gabor Brasnjo, Thomas S Otis. Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression[J].Neuron, 2001, 31(4): 607-616.

[5] Adrian L Lopresti, Garth L Maker, Sean D Hood, et al. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2014, 48: 102-111.

[6] Ana Paula Kallaur, Josiane Lopes, Sayonara Rangel Oliveira, et al. Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased poeripheral inflammation but less acute neuroinflammation[J].Molecular neurobiology, 2015, DOI:10.1007/s12035-015-9443-47.

[7] Nataliia Bakunina, Carmine M Pariante, Patricia A Zunszain. Immune mechanisms linked to depression via oxidative stress and neuroprogression[J].Immunology, 2015, 144(3): 365–373.

[8] Ashutosh Bajpai, Akhilesh Kumar Verma, Mona Srivastava, et al. Oxidative stress and major depression[J].J Clinical Diagnostic Research: JCDR, 2014, 8(12):CC04-07.

[9] George Anderson, Michael Maes. Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications[J].Current Pharmaceutical Design, 2014, 20(23): 3812-3847.

[10] Hasan Herken, Ahmet Gurel, Salih Selek, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment[J].Archives of Medical Research, 2007, 38(2): 247-252.

[11] Priya Palta, Laura J Samuel, Edgar R Miller, et al. Depression and oxidative stress: results from a meta-analysis of observational studies[J].Psychosomatic Medicine, 2014, 76(1):12-19.

[12] Sara A Gibson, Zeljka Korade, Richard C Shelton. Oxidative stress and glutathione response in tissue cultures from persons with major depression[J].J Psychiatric Research, 2012, 46(10): 1326-1332.

[13] Chung Sooyoung, Li Xiang-rui, Sacha B Nelson. Short-term depression at thalamocortical synapses contributes to rapid adaptation of cortical sensory responses in vivo[J].Neuron, 2002, 34(3):437-446.

[14] George Anderson, Michael Berk, Olivia Dean, et al. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications[J].CNS Drugs, 2014, 28(1):1-10.

[15] Michael Maes. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression[J]. Neuro Endocrinology Letters, 2008, 29(3): 287-291.

[16] Michael Maes, Piotr Galecki, Chang Yong-Seun, et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2011, 35(3): 676-692.

[17] Yao Wei, Zhang Ji-chun, Tamaki Ishima, et al. Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice[J].Scientific Reports, 2016, 6: 30659.

[18] Andrew H Miller, Charles L Raison. The role of inflammation in depression: from evolutionary imperative to modern treatment target[J].Nature Reviews Immunology, 2016, 16(1):22-34.

[19] Steven Moylan, Michael Berk, Olivia M Dean, et al. Oxidative & nitrosative stress in depression: why so much stress? [J]Neuroscience and Biobehavioral Reviews, 2014, 45: 46-62.

[20] India Mendez-David, Laurent Tritschler, Zeina EI Ali, et al. Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression[J].Neuroscience Letters, 2015, 597: 121-126.

[21] Heber Vargas, Sandra Odebrecht Vargas Nunes, Marcia de Castro, et al. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence[J].Neuroscience Letters, 2013, 544: 136-140.

[22] James W Kaspar, Suryakant K Niture, Anil K Jaiswal. Nrf2:INrf2 (Keap1) signaling in oxidative stress[J].Free Radical Biology & Medicine, 2009, 47(9): 1304-1309.

[23] Sreedevi Rejitha, Prathibha P, Madambath Indira. Nrf2-mediated antioxidant response by ethanolic extract of Sida cordifolia provides protection against alcohol-induced oxidative stress in liver by upregulation of glutathione metabolism[J].Redox Report : Communications in Free Radical Research, 2015, 20(2): 75-80.

[24] Chen Xiao-pan, Liu Jie, Chen Shao-yu. Over-expression of Nrf2 diminishes ethanol-induced oxidative stress and apoptosis in neural crest cells by inducing an antioxidant response[J].Reproductive Toxicology, 2013, 42: 102-109.

[25] Zhang Hong-qiao, Kelvin J A Davies, Henry Forman. Oxidative stress response and Nrf2 signaling in aging[J].Free Radical Biology & Medicine, 2015, 88(Pt B):314-336.

[26] Swetha Rudraiah, Gu Xin-sheng, Ronald N Hines, et al. Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells[J].Toxicology in vitro, 2016, 31:54-59.

[27] Li Li, Du Ji-kun, Lian Yaru, et al. Protective effects of coenzyme Q10 against hydrogen peroxide-induced oxidative stress in PC12 cell: the role of Nrf2 and antioxidant enzymes[J].Cellular and Molecular Neurobiology, 2016, 36(1):103-111.

[28] Seyha Seng, Hava Karsenty Avraham, Gabriel Birrane, et al. Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response[J].J Biological Chemistry, 2010, 285(34): 26190-26198.

[29] Li Li, Li Wei, Jung Sang-won, et al. Protective effects of decursin and decursinol angelate against amyloid beta-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes[J].Bioscience, Biotechnology, Biochemistry, 2011, 75(3): 434-442.

[30] Stacey Ruiz, Pablo E Pergola, Richard A Zager, et al. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease[J].Kidney International, 2013, 83(6): 1029-1041.

[31] Silivia Guzman-Beltran, Sandra Espada, Marisol Orozco-Ibarra, et al. Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress[J].Neuroscience Letters, 2008, 447(2-3): 167-171.

[32] Joanna Wardyn, Amy Ponsford, Christopher M Sanderson. Dissecting molecular cross-talk between Nrf2 and NF-kappaB response pathways[J].Biochemical Society Transactions, 2015, 43(4): 621-626.

[33] Jiang Guan-jun, Liu Xiu-heng, Wang Min, et al. Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway[J].Acta Cirurgica Brasileira, 2015, 30(6):422-429.

[34] Cui Wen-peng, Bai Yang, Luo Ping, et al. Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury[J].Oxidative Medicine Cellular Longevity, 2013, 2013(10): 306073.

[35] Michael Maes, Zdenek Fisar, Miguel Medina, et al. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors[J].Inflammopharmacology, 2012, 20(3):127-150.

[36] Sahin K, Orhan C, Tuzcu Z, et al. Curcumin ameloriates heat stress via inhibition of oxidative stress and modulation of Nrf2/HO-1 pathway in quail[J].Food Chemical Toxicology, 2012, 50(11):4035-4041.

[37] Zhang Y, Zhang L, Chu W, et al. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes[J].Cellular Physiology Biochemistry, 2010, 26(6): 991-998.

Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64.
[2]	LIN Si-mei, ZHOU Hong, YANG Bao-xue.The Relationship between Hyperuricemia and Chronic Kidney Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 55-64.
[3]	王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72.
[4]	LIU Cai-hong，WU Xian，TANG Su-su，HONG Hao*.Involvement of TGR5 in Aβ-Induced Neurotoxicity in Vivo[J]. Acta Neuropharmacologica, 2018, 8(4): 11-12.
[5]	WU Xian, LV Yang-ge, TANG Su-Su, HONG Hao.Involvement of TGR5 in Aβ-induced Neurotoxicity in Vivo[J]. Acta Neuropharmacologica, 2018, 8(4): 53-54.
[6]	ZHONG Jia-hong, WANG Hai-tao, XU Jiang-ping.Inhibition of Phosphodiesterase 4 by FCPR16 Protects SH-SY5Y Cells against MPP+-Induced Cell Death through Activating cAMP/PKA/CREB and Epac/Akt Signaling Pathways[J]. Acta Neuropharmacologica, 2018, 8(4): 54-55.
[7]	BAI Ru-bing，ZHANG Zhong-quan，CEN Juan.The Expression of P-Glycoprotein in Neurons and the Effect of Oxidative Stress on P-Glycoprotein[J]. Acta Neuropharmacologica, 2018, 8(3): 9-.
[8]	YANG Jie，LIU Fu-jia，TIAN Zi-xia，WANG Le-le，XIE Xin-mei，PANG Xiao-bin.Neuroprotective Effect of Mailuoning on MCAO Rats and Its Antioxidant Mechanism[J]. Acta Neuropharmacologica, 2017, 7(4): 1-7.
[9]	DU Yun-guang，CAO Xin-xin，WANG Xiao-ru，WANG Shu-hua.Protective Effect of Vitexin on Cerebral Ischemia-Reperfusion Injury in Rats[J]. Acta Neuropharmacologica, 2017, 7(1): 10-23.
[10]	WANG Ming-lei，WANG Wen-ge，ZHANG Jun-hong.Effects of Different Challenging Time on Airway Inflammation and Airway Remodeling of an Asthmatic Mouse Model[J]. Acta Neuropharmacologica, 2017, 7(1): 29-37.
[11]	DU Guan-tao，ZHANG Chun-teng，HONG Hao.Progress on Research of 5-Lipoxygenase in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2016, 6(5): 39-44.
[12]	ZHANG Mei-jin，WANG Sha-sha，ZHANG Zhao，CHEN Nai-hong，HU Jin-feng.Role of Nuclear Transcription Factor Nrf2 in Parkinson’s Disease[J]. Acta Neuropharmacologica, 2016, 6(1): 35-40.
[13]	LOU Yu-xia, ZHANG Zhao, WANG Zhen-zhen, JIANG Yi-na, ZHANG Yi, LI Lin, CHEN Nai-hong.Parkinson Associated DJ-1 Gene and Oxidative Stress[J]. ACTA NEUROPHARMACOLOGICA, 2016, 6(1): 58-64.
[14]	WANG Ying-ying, SONG Xiu-yun, WANG Qi, CHEN Nai-hong.Application of Natural Antioxidants in the Progress of Alzheimer's Disease[J]. Acta Neuropharmacologica, 2015, 5(6): 30-34.
[15]	ZHANG Jing, ZOU Yu-an, Dong Xiao-hua.Research Progress on the Protective Eff ect of Cerebral Ischemia Preconditioning on Cerebral Ischemia Injury[J]. Acta Neuropharmacologica, 2015, 5(5): 57-64.